Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

De 2015-09-01 à 2019-08-31, projet en cours

Détails concernant le projet

Coût total:

EUR 6 510 741,95

Contribution de l'UE:

EUR 5 980 435

Coordonné à/au(x)/en:

France

Appel à propositions:

H2020-PHC-2014-two-stageSee other projects for this call

Régime de financement:

RIA - Research and Innovation action

Objectif

Coordinateur

CENTRE HOSPITALIER UNIVERSITAIRE
France

Contribution de l'UE: EUR 1 193 572,80


PLACE DU PR ROBERT DEBRE
30900 NIMES
France
Activity type: Research Organisations

Contact the organisation

Participants

ICON CLINICAL RESEARCH LIMITED
Ireland

Contribution de l'UE: EUR 698 821


SOUTH COUNTY BUSINESS PARK, LEOPARDSTOWN
18 DUBLIN
Ireland
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

MOTOR NEURONE DISEASE ASSOCIATION
United Kingdom

Contribution de l'UE: EUR 0


10 15 NOTRE DAME MEWS
NN1 2BG NORTHAMPTON
United Kingdom
Activity type: Other

Contact the organisation

WGK CONSULTANCY LTD
United Kingdom

Contribution de l'UE: EUR 452 900,20


29 SISH LANE
SG1 3LS STEVENAGE
United Kingdom
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation